BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7705689)

  • 1. Peritoneal papillary serous carcinoma arising in an infertile woman during ovulation-induction therapy: immunohistochemical expression of LH/hCG receptors.
    Komatsu T; Konishi I; Mandai M; Koshiyama M; Nanbu K; Yamamoto S; Kanzaki H; Rao CV; Mori T
    Gynecol Oncol; 1995 Mar; 56(3):470-4. PubMed ID: 7705689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid growth of an ovarian clear cell carcinoma expressing LH/hCG receptor arising from endometriosis during early pregnancy.
    Kobayashi F; Monma C; Nanbu K; Konishi I; Sagawa N; Mori T
    Gynecol Oncol; 1996 Aug; 62(2):309-13. PubMed ID: 8751567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful.
    Barnetson RJ; Burnett RA; Downie I; Harper CM; Roberts F
    Am J Clin Pathol; 2006 Jan; 125(1):67-76. PubMed ID: 16482993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case.
    Kaplan EJ; Caputo TA; Shen PU; Sassoon RI; Soslow RA
    Gynecol Oncol; 1998 Aug; 70(2):289-94. PubMed ID: 9740708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma.
    Killackey MA; Davis AR
    Gynecol Oncol; 1993 Nov; 51(2):171-4. PubMed ID: 8276289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
    Comin CE; Saieva C; Messerini L
    Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serous peritoneal papillary tumor of low malignancy potential. Report of a case].
    Mayerson D; Rondini C; Braun H; Chuaqui R; Brañes J
    Rev Med Chil; 2000 Feb; 128(2):206-10. PubMed ID: 10962890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary serous carcinoma of peritoneum: case study and review of the literature on the differential diagnosis of malignant peritoneal tumors.
    Koutselini HA; Lazaris AC; Thomopoulou G; Papayannopoulou A; Kairi-Vasilatou E
    Adv Clin Path; 2001 Jul; 5(3):99-104. PubMed ID: 11753882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas.
    Ordóñez NG
    Hum Pathol; 2005 Nov; 36(11):1163-7. PubMed ID: 16260268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer after successful ovulation induction: a case report.
    Hull ME; Kriner M; Schneider E; Maiman M
    J Reprod Med; 1996 Jan; 41(1):52-4. PubMed ID: 8855076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peritoneal papillary serous carcinoma: clinical report].
    Stagnitti F; Mongardini M; Schillaci F; Scirocchi R; De Petris L; Malizia A; Marenga G; Patrizi V; Priore FM; Corona F; Tiberi R; Di Placido M; Calderisi MD; Longo F
    G Chir; 2002 Oct; 23(10):379-82. PubMed ID: 12611260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extraovarian peritoneal serous papillary carcinoma: studies of clinical and pathological features].
    Shi X; Guo Y; Li J
    Zhonghua Fu Chan Ke Za Zhi; 1996 Dec; 31(12):711-3. PubMed ID: 9387509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary malignant mesothelioma of the peritoneum: a clinical and immunohistochemical study.
    Markaki S; Protopapas A; Milingos S; Lazaris D; Antsaklis A; Michalas S
    Gynecol Oncol; 2005 Mar; 96(3):860-4. PubMed ID: 15721439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serous papillary cystadenocarcinoma of the recto-vaginal septum: a rare primary localization].
    Leteurtre E; Boman F; Farine MO; Querleu D; Gosselin B
    Ann Pathol; 1999 Mar; 19(1):42-5. PubMed ID: 10320912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum.
    Schorge JO; Miller YB; Qi LJ; Muto MG; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2000 Mar; 76(3):369-72. PubMed ID: 10684712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal papillary serous cystadenocarcinoma at a previous laparoscopic trocar site.
    Wang LM; Jeng CJ; Lin SE; Shen J
    Taiwan J Obstet Gynecol; 2012 Sep; 51(3):463-4. PubMed ID: 23040941
    [No Abstract]   [Full Text] [Related]  

  • 18. Longitudinal CA125 detection of sporadic papillary serous carcinoma of the peritoneum.
    Skates S; Troiano R; Knapp RC
    Int J Gynecol Cancer; 2003; 13(5):693-6. PubMed ID: 14675358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ovarian cancer prognosis and expression of receptors to sex hormones and proliferative activity of tumor cells].
    Novichkov EV; Votintsev AA
    Arkh Patol; 2006; 68(2):10-3. PubMed ID: 16752501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary cystadenocarcinoma arising in a paratubal mesothelial cyst of the mesosalpinx--a case report.
    Narurkar SD; Buch AC; Patel KD; Avasare SS; Niyogi GM
    Indian J Cancer; 2001; 38(2-4):137-42. PubMed ID: 12593453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.